Abcellera Biologics Inc Net Asset Quality Index

Latest as of June 2026: 68.5%

Abcellera Biologics Inc net asset quality index. Abcellera Biologics Inc (ABCL) has a Net Asset Quality Index of 68.5% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $1.31 Billion minus total liabilities of $411.56 Million yields net assets of $896.02 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check ABCL cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

Quality Index

68.5%
Equity / Total Assets

Net Assets

$896.02 Million
USD

Total Assets

$1.31 Billion
USD

Total Liabilities

$411.56 Million
USD

Net Asset Quality Index of Abcellera Biologics Inc (2018–2025)

Net asset quality index of Abcellera Biologics Inc from 2018 to 2025. This chart shows how Abcellera Biologics Inc's Net Asset Quality Index has evolved across 8 annual periods from 2018 to 2025. As of June 2026, the index stands at 68.5%, representing net assets of $896.02 Million against total assets of $1.31 Billion USD. See ABCL net assets for net asset value and shareholders' equity analysis.

Abcellera Biologics Inc Net Asset Quality Index by Year (2018–2025)

Abcellera Biologics Inc net asset quality index by year from 2018 to 2025. The table below presents the year-by-year Net Asset Quality Index for Abcellera Biologics Inc from 2018 to 2025, covering 8 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see how much is Abcellera Biologics Inc worth.

Year Quality Index Net Assets (USD) Total Assets Total Liabilities Change (pp)
2025 71.3% $966.90 Million $1.36 Billion $390.05 Million ▼ -6.4 pp
2024 77.6% $1.06 Billion $1.36 Billion $304.47 Million ▲ +0.2 pp
2023 77.4% $1.15 Billion $1.49 Billion $335.78 Million ▼ -2.6 pp
2022 80.0% $1.23 Billion $1.54 Billion $307.63 Million ▲ +2.2 pp
2021 77.8% $1.03 Billion $1.32 Billion $292.84 Million ▼ -4.8 pp
2020 82.6% $830.51 Million $1.01 Billion $175.03 Million ▲ +38.9 pp
2019 43.6% $10.25 Million $23.49 Million $13.24 Million ▼ -10.4 pp
2018 54.0% $11.61 Million $21.49 Million $9.88 Million —
pp = percentage points